Back to Search
CHRISTOPHER MCGINN, MD
MD
Vascular & Interventional Radiology Physician
NPI: 1871835413IndividualAccepts Medicare
Specialties, Licenses & Credentials
Vascular & Interventional Radiology PhysicianPrimary
Radiology — Vascular & Interventional Radiology
Code: 2085R0204X
D0087123(MD)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 2013
Research & Publications (20)
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
PMID 18281668·J Clin Oncol·2008
3-trial
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
PMID 17762432·Am J Clin Oncol·2007
3-trial
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.
PMID 17560050·Int J Radiat Oncol Biol Phys·2007
8-other
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
PMID 16418882·Ann Surg Oncol·2006
3-trial
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
PMID 15993549·Int J Radiat Oncol Biol Phys·2005
8-other
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
PMID 15625365·J Clin Oncol·2005
3-trial
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
PMID 15275733·Int J Radiat Oncol Biol Phys·2004
3-trial
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
PMID 15234045·Int J Radiat Oncol Biol Phys·2004
3-trial
Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.
PMID 14665608·J Clin Oncol·2004
3-trial
Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials.
PMID 12826246·Int J Radiat Oncol Biol Phys·2003
6-review
Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
PMID 14679011·Cancer Res·2003
7-preclinical
Conformal chemoradiation for primary and metastatic liver malignancies.
PMID 14648782·Semin Surg Oncol·2003
6-review
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
PMID 12520460·Semin Radiat Oncol·2003
6-review
Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.
PMID 12436445·Cancer·2002
5-case
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
PMID 12209674·Cancer·2002
6-review
Analysis of radiation-induced liver disease using the Lyman NTCP model.
PMID 12095546·Int J Radiat Oncol Biol Phys·2002
8-other
Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.
PMID 12007952·Int J Radiat Oncol Biol Phys·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1701 TWIN SPRINGS RD
HALETHORPE, MD 21227 - Phone
- (703) 359-7878
Quick Facts
- NPI
- 1871835413
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile